$153.49
1.07% yesterday
NYSE, Feb 04, 10:00 pm CET
ISIN
US4781601046
Symbol
JNJ

Johnson & Johnson Stock price

$153.49
+9.83 6.84% 1M
-7.76 4.81% 6M
+8.87 6.13% YTD
-2.31 1.48% 1Y
-18.14 10.57% 3Y
+1.89 1.25% 5Y
+52.13 51.43% 10Y
NYSE, Closing price Tue, Feb 04 2025
+1.62 1.07%
ISIN
US4781601046
Symbol
JNJ
Sector
Industry

Key metrics

Market capitalization $369.55b
P/E (TTM) P/E ratio 26.48
P/S ratio (TTM) P/S ratio 4.16
P/B ratio (TTM) P/B ratio 5.27
Dividend yield 3.20%
Last dividend (FY24) $4.91
Revenue growth (TTM) Revenue growth -4.51%
Revenue (TTM) Revenue $88.82b
EBIT (operating result TTM) EBIT $21.02b
Cash position $20.30b
EPS (TTM) EPS $5.80
Short interest 0.68%
Show more

Create a Free Account to create an Johnson & Johnson alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Johnson & Johnson Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Johnson & Johnson forecast:

11x Buy
48%
12x Hold
52%

Analyst Opinions

23 Analysts have issued a Johnson & Johnson forecast:

Buy
48%
Hold
52%

Financial data from Johnson & Johnson

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
88,820 88,820
5% 5%
100%
- Direct Costs 26,518 26,518
11% 11%
30%
67,745 67,745
7% 7%
76%
- Selling and Administrative Expenses 24,040 24,040
45% 45%
27%
- Research and Development Expense 17,244 17,244
13% 13%
19%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 21,018 21,018
12% 12%
24%
Net Profit 14,066 14,066
1% 1%
16%

In millions USD.

Don't miss a Thing! We will send you all news about Johnson & Johnson directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Johnson & Johnson Stock News

Neutral
Business Wire
one day ago
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the 45th Annual TD Cowen Healthcare Conference on Tuesday, March 4th, 2025. Management will participate in a fireside chat at 11:10 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition of...
Positive
Seeking Alpha
2 days ago
A buy-and-hold strategy is ideal for investors seeking durable companies with strong dividends and attractive valuations, avoiding tax inefficiencies from frequent trading. UPS offers a 5.7% dividend yield, trading at a forward P/E of 13.5, with potential for profitability expansion despite near-term Amazon volume reductions. Johnson & Johnson, with a 3.3% dividend yield and a forward P/E of 14...
Positive
The Motley Fool
3 days ago
Johnson & Johnson (JNJ -0.47%) is one of the world's largest and most prominent healthcare leaders. If investing in a company came down to size, the stock would be a no-brainer buy.
More Johnson & Johnson News

Company Profile

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Head office United States
CEO Joaquin Duato
Founded 1887
Website www.jnj.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today